Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Tartaglia Lab, |
RCV001261415 | SCV001337684 | pathogenic | Heart, malformation of; Atypical behavior; Abnormal facial shape; Specific learning disability; Macrocephaly | 2020-04-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV002555438 | SCV002961454 | pathogenic | not provided | 2021-12-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 917744). This missense change has been observed in individual(s) with a neurodevelopmental condition (PMID: 32721402; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 174 of the MAPK1 protein (p.Ala174Val). |
OMIM | RCV001264763 | SCV001443066 | pathogenic | Noonan syndrome 13 | 2020-11-09 | no assertion criteria provided | literature only |